中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2014年
21期
37-38
,共2页
血清降钙素原%医院获得性肺炎%疗效评估
血清降鈣素原%醫院穫得性肺炎%療效評估
혈청강개소원%의원획득성폐염%료효평고
Serum procalcitonin%Hospital-acquired Pneumonia%Efficacy Evaluation
目的：分析血清降钙素原（PCT）在评估医院内获得性肺炎治疗效果中的价值。方法回顾性分析对我院2011年1月-2014年1月住院部收治的168例医院获得性肺炎患者，根据是否动态检测PCT分为观察组与对照组。观察组患者根据血清降钙素原的监测结果进行抗菌治疗，对照组给予常规的抗感染治疗；分析比较两组患者的临床疗效，包括抗生素使用疗程、住院时间、住院费用等。结果血清降钙素原（PCT）监测对医院内获得性性肺炎的诊断的特异性高达100.0%，敏感性达97.62%。两组患者的抗生素使用时间、住院时间、住院费用、细菌耐药率，比较t分别为，P＜0.05，差异具有统计学意义。结论血清降钙素原在医院内获得性肺炎的治疗中起到了指导性作用，能减少抗生素使用疗程、住院时间、住院费用，可作为指导抗菌治疗的指标。
目的：分析血清降鈣素原（PCT）在評估醫院內穫得性肺炎治療效果中的價值。方法迴顧性分析對我院2011年1月-2014年1月住院部收治的168例醫院穫得性肺炎患者，根據是否動態檢測PCT分為觀察組與對照組。觀察組患者根據血清降鈣素原的鑑測結果進行抗菌治療，對照組給予常規的抗感染治療；分析比較兩組患者的臨床療效，包括抗生素使用療程、住院時間、住院費用等。結果血清降鈣素原（PCT）鑑測對醫院內穫得性性肺炎的診斷的特異性高達100.0%，敏感性達97.62%。兩組患者的抗生素使用時間、住院時間、住院費用、細菌耐藥率，比較t分彆為，P＜0.05，差異具有統計學意義。結論血清降鈣素原在醫院內穫得性肺炎的治療中起到瞭指導性作用，能減少抗生素使用療程、住院時間、住院費用，可作為指導抗菌治療的指標。
목적：분석혈청강개소원（PCT）재평고의원내획득성폐염치료효과중적개치。방법회고성분석대아원2011년1월-2014년1월주원부수치적168례의원획득성폐염환자，근거시부동태검측PCT분위관찰조여대조조。관찰조환자근거혈청강개소원적감측결과진행항균치료，대조조급여상규적항감염치료；분석비교량조환자적림상료효，포괄항생소사용료정、주원시간、주원비용등。결과혈청강개소원（PCT）감측대의원내획득성성폐염적진단적특이성고체100.0%，민감성체97.62%。량조환자적항생소사용시간、주원시간、주원비용、세균내약솔，비교t분별위，P＜0.05，차이구유통계학의의。결론혈청강개소원재의원내획득성폐염적치료중기도료지도성작용，능감소항생소사용료정、주원시간、주원비용，가작위지도항균치료적지표。
Objective To look into the value of monitoring of serum procalcitonin in treating hospital-acquired pneumonia. Methods One hundred and sixty eight patients with hospital acquired pneumonia admiited by this hosptial were studied , and they were divided into the observation group and the control group according to the availability of bacteria infection, patients in the observation group suffered from bacteria infectious pneumonia patients and they were subject to antibacterial treatment according to monitoring results of serum procalcitonin, patients in the control group suffered from non-bacteria infectious pneumonia, and they were subject to routine anti-infection treatment, clinical efficacy of patients in two groups were compared and analyzed. Re-sults The specificity of the monitoring of serum procalcitonin (PCT) monitoring in the diagnosis of nosocomial acquired pneumonia hit as high as 100.0%, and the sensitivity hit 97.62%. The comparison in PCT level of patients in two gorups before and after the treatment hit 13.1692 and 7.9565 respectively, the average value of p was less than 0.05, and the difference was statistically sig-nificant.Conclusion The serum procalcitonin plays the guiding function in the treatment of hospital acquired pneumonia, and de-livers better therapeutic efficacy when compared to traditional method, being qualified to serve as the index to guide antibacterial therapy.
